Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
KEGG | hsa05130 | Pathogenic Escherichia coli infection | 48/1169 | 197/8135 | 0.0001141 | 0.001905 | 0.001345 | 48 | RABC64 | |
KEGG | hsa05163 | Human cytomegalovirus infection | 53/1169 | 225/8135 | 0.000132 | 0.0021 | 0.001483 | 53 | RABC64 | |
KEGG | hsa04657 | IL-17 signaling pathway | 27/1169 | 94/8135 | 0.0002239 | 0.0034 | 0.0024 | 27 | RABC64 | |
KEGG | hsa05132 | Salmonella infection | 56/1169 | 249/8135 | 0.0003132 | 0.004548 | 0.00321 | 56 | RABC64 | |
KEGG | hsa04060 | Cytokine-cytokine receptor interaction | 64/1169 | 295/8135 | 0.0003489 | 0.004856 | 0.003428 | 64 | RABC64 | |
KEGG | hsa05416 | Viral myocarditis | 19/1169 | 60/8135 | 0.0004933 | 0.006591 | 0.004653 | 19 | RABC64 | |
KEGG | hsa05142 | Chagas disease | 27/1169 | 102/8135 | 0.0009209 | 0.01183 | 0.008351 | 27 | RABC64 | |
KEGG | hsa05163 | Human cytomegalovirus infection | 40/792 | 225/8135 | 0.0001137 | 0.03718 | 0.03423 | 40 | RABC93 | |
KEGG | hsa05165 | Human papillomavirus infection | 51/792 | 331/8135 | 0.0005685 | 0.09295 | 0.08558 | 51 | RABC93 | |
KEGG | hsa05169 | Epstein-Barr virus infection | 97/1765 | 202/8135 | 4.58e-17 | 0.0000000000000153 | 0.00000000000000955 | 97 | RABC10 | |
KEGG | hsa05416 | Viral myocarditis | 38/1765 | 60/8135 | 0.00000000000374 | 0.000000000448 | 0.00000000028 | 38 | RABC10 | |
KEGG | hsa04380 | Osteoclast differentiation | 63/1765 | 128/8135 | 0.00000000000403 | 0.000000000448 | 0.00000000028 | 63 | RABC10 | |
KEGG | hsa05130 | Pathogenic Escherichia coli infection | 83/1765 | 197/8135 | 0.0000000000564 | 0.00000000382 | 0.00000000239 | 83 | RABC10 | |
KEGG | hsa05140 | Leishmaniasis | 43/1765 | 77/8135 | 0.0000000000574 | 0.00000000382 | 0.00000000239 | 43 | RABC10 | |
KEGG | hsa05164 | Influenza A | 74/1765 | 171/8135 | 0.000000000142 | 0.00000000788 | 0.00000000493 | 74 | RABC10 | |
KEGG | hsa05171 | Coronavirus disease - COVID-19 | 91/1765 | 232/8135 | 0.000000000649 | 0.0000000271 | 0.000000017 | 91 | RABC10 | |
KEGG | hsa05132 | Salmonella infection | 96/1765 | 249/8135 | 0.000000000651 | 0.0000000271 | 0.000000017 | 96 | RABC10 | |
KEGG | hsa04210 | Apoptosis | 60/1765 | 136/8135 | 0.00000000325 | 0.00000012 | 0.0000000752 | 60 | RABC10 | |
KEGG | hsa04666 | Fc gamma R-mediated phagocytosis | 47/1765 | 97/8135 | 0.00000000423 | 0.00000013 | 0.0000000811 | 47 | RABC10 | |
KEGG | hsa04062 | Chemokine signaling pathway | 77/1765 | 192/8135 | 0.00000000428 | 0.00000013 | 0.0000000811 | 77 | RABC10 | |
KEGG | hsa04940 | Type I diabetes mellitus | 27/1765 | 43/8135 | 0.0000000068 | 0.000000189 | 0.000000118 | 27 | RABC10 | |
KEGG | hsa05166 | Human T-cell leukemia virus 1 infection | 85/1765 | 222/8135 | 0.00000000931 | 0.000000238 | 0.000000149 | 85 | RABC10 | |
KEGG | hsa05145 | Toxoplasmosis | 51/1765 | 112/8135 | 0.0000000135 | 0.000000321 | 0.000000201 | 51 | RABC10 | |
KEGG | hsa05152 | Tuberculosis | 72/1765 | 180/8135 | 0.0000000156 | 0.000000346 | 0.000000216 | 72 | RABC10 | |
KEGG | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 76/1765 | 194/8135 | 0.0000000182 | 0.000000378 | 0.000000237 | 76 | RABC10 | |
KEGG | hsa04064 | NF-kappa B signaling pathway | 48/1765 | 104/8135 | 0.0000000212 | 0.000000415 | 0.00000026 | 48 | RABC10 | |
KEGG | hsa05323 | Rheumatoid arthritis | 44/1765 | 93/8135 | 0.0000000327 | 0.000000605 | 0.000000379 | 44 | RABC10 | |
KEGG | hsa05330 | Allograft rejection | 24/1765 | 38/8135 | 0.0000000403 | 0.000000707 | 0.000000442 | 24 | RABC10 | |
KEGG | hsa04662 | B cell receptor signaling pathway | 40/1765 | 82/8135 | 0.0000000475 | 0.000000791 | 0.000000495 | 40 | RABC10 | |
KEGG | hsa04520 | Adherens junction | 36/1765 | 71/8135 | 0.0000000632 | 0.000000991 | 0.000000621 | 36 | RABC10 |